StockData
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. (RDHL) income statement

RDHLNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 0/30
$0.28−0.04 (-13.08%)

Close on Nov 20, 2026Market cap $1.43MP/E –Yield –

See a number that looks wrong?